Skip to Main Content

Browse issues

Clinical Infectious Diseases Cover Image for Volume 55, Issue 12
Volume 55, Issue 12
15 December 2012
ISSN 1058-4838
EISSN 1537-6591

Volume 55, Issue 12, 15 December 2012

NEWS

Clinical Infectious Diseases, Volume 55, Issue 12, 15 December 2012, Pages i–ii, https://doi.org/10.1093/cid/cis877

IN THE LITERATURE

Clinical Infectious Diseases, Volume 55, Issue 12, 15 December 2012, Pages iii–iv, https://doi.org/10.1093/cid/cis898

ARTICLES AND COMMENTARIES

Volker H. Hackert and others
Clinical Infectious Diseases, Volume 55, Issue 12, 15 December 2012, Pages 1591–1599, https://doi.org/10.1093/cid/cis734

We present an essential prospective case study linking a veterinary outbreak of Q fever on a single dairy-goat farm to a human Q-fever cluster with massive numbers of undetected infections and exceedingly high attack rates across an entire region.

Julia V. Ershova and others
Clinical Infectious Diseases, Volume 55, Issue 12, 15 December 2012, Pages 1600–1607, https://doi.org/10.1093/cid/cis748

This study provides the first comprehensive assessment of acquired resistance predictors for 2 key classes of second-line antituberculosis drugs that may help identify patients at greater risk for developing extensively drug-resistant tuberculosis.

David Dix and others
Clinical Infectious Diseases, Volume 55, Issue 12, 15 December 2012, Pages 1608–1614, https://doi.org/10.1093/cid/cis774

We conducted a retrospective study of infectious outcomes in children with acute myeloid leukemia. Duration of corticosteroid exposure was significantly associated with microbiologically documented sterile site infection, bacteremia, fungal infection, sepsis, and infectious death.

Damaris Fröhlich Knaute and others
Clinical Infectious Diseases, Volume 55, Issue 12, 15 December 2012, Pages 1615–1622, https://doi.org/10.1093/cid/cis757

The serological response to treatment was studied in 264 syphilis patients; it was influenced by syphilis stage but not by human immunodeficiency virus infection and reinfection. Some of the recommendations of current guidelines are critically discussed, and amendments are proposed.

Edward W. Hook
Clinical Infectious Diseases, Volume 55, Issue 12, 15 December 2012, Pages 1623–1624, https://doi.org/10.1093/cid/cis766
Philipp Zanger and others
Clinical Infectious Diseases, Volume 55, Issue 12, 15 December 2012, Pages 1625–1632, https://doi.org/10.1093/cid/cis778

Colonized human nares are important for the spread of Staphylococcus aureus infections. The common use of hormonal contraception seems to substantially increase this reservoir, with potential impact on S. aureus infections and transmission.

Matthieu Schmidt and others
Clinical Infectious Diseases, Volume 55, Issue 12, 15 December 2012, Pages 1633–1641, https://doi.org/10.1093/cid/cis783

Patients who received the latest generation venoarterial extracorporeal membrane oxygenation (ECMO) for refractory cardiogenic shock still had a high risk of developing nosocomial infections, particularly ventilator-associated pneumonia. Rates of nosocomial infections increased with longer ECMO support, and infection severity was independently associated with in–intensive care unit death.

Takafumi Okada and others
Clinical Infectious Diseases, Volume 55, Issue 12, 15 December 2012, Pages 1642–1649, https://doi.org/10.1093/cid/cis784

An outbreak of Mycoplasma pneumoniae pneumonia occurred among children throughout Japan in 2011. Eighty-seven percent of isolates were macrolide resistant. Minocycline and doxycycline were significantly more effective clinically in reducing bacterial DNA in samples than tosufloxacin.

Cécile Bébéar
Clinical Infectious Diseases, Volume 55, Issue 12, 15 December 2012, Pages 1650–1651, https://doi.org/10.1093/cid/cis791
Jonathan S. Zipursky and others
Clinical Infectious Diseases, Volume 55, Issue 12, 15 December 2012, Pages 1652–1658, https://doi.org/10.1093/cid/cis809

Despite a widely held belief that the aesthetics of fecal microbiota transplantation (FMT) would limit its use in clinical practice, it appears that patients are open to FMT as an alternative treatment in the setting of recurrent Clostridium difficile infection.

Lawrence J. Brandt
Clinical Infectious Diseases, Volume 55, Issue 12, 15 December 2012, Pages 1659–1660, https://doi.org/10.1093/cid/cis812
Seth T. Walk and others
Clinical Infectious Diseases, Volume 55, Issue 12, 15 December 2012, Pages 1661–1668, https://doi.org/10.1093/cid/cis786

The association between hypervirulent ribotype and severe Clostridium difficile infection was nonsignificant after adjustment for microbiologic, epidemiologic, and laboratory variables. This nonsignificant association was further validated using an independent data set.

Frédéric Barbut and Maja Rupnik
Clinical Infectious Diseases, Volume 55, Issue 12, 15 December 2012, Pages 1669–1672, https://doi.org/10.1093/cid/cis790

BRIEF REPORT

Jukka Jokinen and others
Clinical Infectious Diseases, Volume 55, Issue 12, 15 December 2012, Pages 1673–1676, https://doi.org/10.1093/cid/cis799

PHOTO QUIZ

Clinical Infectious Diseases, Volume 55, Issue 12, 15 December 2012, Page 1677, https://doi.org/10.1093/cid/cis663

INVITED ARTICLE

IMMUNOCOMPROMISED HOSTS

Adrian Egli and others
Clinical Infectious Diseases, Volume 55, Issue 12, 15 December 2012, Pages 1678–1689, https://doi.org/10.1093/cid/cis818

Cellular assays to detect cell-mediated immunity to cytomegalovirus are under development and may be useful tools for refining prevention and treatment in organ transplant patients. We review the utility and potential clinical applications of these assays.

HIV/AIDS

Elvin H. Geng and others
Clinical Infectious Diseases, Volume 55, Issue 12, 15 December 2012, Pages 1690–1697, https://doi.org/10.1093/cid/cis750

A recommendation by San Francisco General Hospital in January 2010 to initiate antiretroviral therapy in all human immunodeficiency virus (HIV)–infected patients led to a rapid increase in HIV RNA suppression among patients with a CD4 cell count of >500 cells/μL after clinic enrollment.

Molebogeng X. Rangaka and others
Clinical Infectious Diseases, Volume 55, Issue 12, 15 December 2012, Pages 1698–1706, https://doi.org/10.1093/cid/cis775

Diagnostic accuracy of symptom screening to rule out tuberculosis among human immunodeficiency virus–infected individuals undergoing screening prior to isoniazid preventive therapy was evaluated. Symptom screening had poor sensitivity, especially among those on antiretroviral therapy. Without culture-based screening, the risk of inadvertently prescribing isoniazid monotherapy is high.

A. Sarah Walker and others
Clinical Infectious Diseases, Volume 55, Issue 12, 15 December 2012, Pages 1707–1718, https://doi.org/10.1093/cid/cis797

In low-income countries, children ≥4 years and adults with low CD4 count have equally high mortality risk in the 3 months after initiation of antiretroviral therapy, similar to that of untreated individuals. Bacterial infections play a major role; targeted interventions could have important benefits.

José A. Mira and others
Clinical Infectious Diseases, Volume 55, Issue 12, 15 December 2012, Pages 1719–1726, https://doi.org/10.1093/cid/cis779

The efficacy of pegylated interferon plus ribavirin in human immunodeficiency virus/hepatitis C virus (HCV)–coinfected patients with compensated cirrhosis is lower than in those without cirrhosis, although this antiviral combination still leads to a substantial rate of sustained virologic response in those carrying HCV genotype 3.

Jeffrey E. Sherwood and others
Clinical Infectious Diseases, Volume 55, Issue 12, 15 December 2012, Pages 1727–1736, https://doi.org/10.1093/cid/cis785

Despite a high prevalence of vitamin D deficiency (VDD) among a predominantly black human immunodeficiency virus (HIV)–infected cohort, deficiency did not explain an observed racial disparity in low bone mineral density. Prevalence of VDD among HIV-infected persons was not significantly different from non-HIV infected controls.

ANSWER TO THE PHOTO QUIZ

Thein Myint and others
Clinical Infectious Diseases, Volume 55, Issue 12, 15 December 2012, Pages 1737–1738, https://doi.org/10.1093/cid/cis668

CORRESPONDENCE

Dafna Yahav and others
Clinical Infectious Diseases, Volume 55, Issue 12, 15 December 2012, Page 1739, https://doi.org/10.1093/cid/cis759
Paul C. McGovern and Alvaro Quintana
Clinical Infectious Diseases, Volume 55, Issue 12, 15 December 2012, Pages 1739–1740, https://doi.org/10.1093/cid/cis760
Paritosh Prasad and others
Clinical Infectious Diseases, Volume 55, Issue 12, 15 December 2012, Pages 1740–1741, https://doi.org/10.1093/cid/cis768
Sahil Khanna and Darrell S. Pardi
Clinical Infectious Diseases, Volume 55, Issue 12, 15 December 2012, Pages 1741–1742, https://doi.org/10.1093/cid/cis722
Radha Rajasingham and David R. Boulware
Clinical Infectious Diseases, Volume 55, Issue 12, 15 December 2012, Pages 1742–1744, https://doi.org/10.1093/cid/cis725
Małgorzata Mikulska and others
Clinical Infectious Diseases, Volume 55, Issue 12, 15 December 2012, Page 1744, https://doi.org/10.1093/cid/cis765
Sue J. Lee and Paul N. Newton
Clinical Infectious Diseases, Volume 55, Issue 12, 15 December 2012, Pages 1744–1745, https://doi.org/10.1093/cid/cis780
Joseph N. Jarvis and others
Clinical Infectious Diseases, Volume 55, Issue 12, 15 December 2012, Pages 1745–1746, https://doi.org/10.1093/cid/cis781
Samad E. J. Golzari and Kamyar Ghabili
Clinical Infectious Diseases, Volume 55, Issue 12, 15 December 2012, Pages 1746–1747, https://doi.org/10.1093/cid/cis825

ERRATA

Clinical Infectious Diseases, Volume 55, Issue 12, 15 December 2012, Page 1748, https://doi.org/10.1093/cid/cis829
Clinical Infectious Diseases, Volume 55, Issue 12, 15 December 2012, Page 1748, https://doi.org/10.1093/cid/cis830

ACKNOWLEDGMENTS

Clinical Infectious Diseases, Volume 55, Issue 12, 15 December 2012, Pages 1749–1755, https://doi.org/10.1093/cid/cis956

COVER/STANDING MATERIAL

Clinical Infectious Diseases, Volume 55, Issue 12, 15 December 2012, Page NP, https://doi.org/10.1093/cid/cis175
Clinical Infectious Diseases, Volume 55, Issue 12, 15 December 2012, Page NP, https://doi.org/10.1093/cid/cis177
Clinical Infectious Diseases, Volume 55, Issue 12, 15 December 2012, Page NP, https://doi.org/10.1093/cid/cis176
Clinical Infectious Diseases, Volume 55, Issue 12, 15 December 2012, Page NP, https://doi.org/10.1093/cid/cis179
Clinical Infectious Diseases, Volume 55, Issue 12, 15 December 2012, Page NP, https://doi.org/10.1093/cid/cis178
Clinical Infectious Diseases, Volume 55, Issue 12, 15 December 2012, Page NP, https://doi.org/10.1093/cid/cis180
Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close